Joseph Michael Fitzgerald
CIK 1484186 · EVP & Group Pres, Cardiology · last filed 2026-02-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
1
Total Filings
128
Lifetime Open-Market Net
-$78.51M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BSXw | EVP & Group Pres, Cardiology | 214,615 | — | — | -$78.51M | 128 | 2026-02-18 |
Recent Filings · Page 3 of 13
128 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-02-20 | BSXw | Mixed | +6,141 | -$374.6K | EDGAR |
| 2024-02-16 | BSXw | Mixed | +2,372 | -$131.2K | EDGAR |
| 2024-02-14 | BSXw | Mixed | −5,450 | $0 | EDGAR |
| 2024-02-08 | BSXw | Mixed | +16,882 | $0 | EDGAR |
| 2024-01-16 | BSXw | Sell (S) | −11,660 | -$699.6K | EDGAR |
| 2024-01-02 | BSXw | Mixed | −12,860 | -$4.39M | EDGAR |
| 2023-09-21 | BSXw | Sell (S) | −15,867 | -$872.7K | EDGAR |
| 2023-05-17 | BSXw | Mixed | −6,418 | -$2.65M | EDGAR |
| 2023-02-22 | BSXw | Mixed | +1,972 | -$88.9K | EDGAR |
| 2023-02-21 | BSXw | Mixed | +6,141 | -$264.8K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.